The discovery of RFI-641 as a potent and selective inhibitor of the respiratory syncytial virus
摘要:
The design and synthesis of a new potent and selective inhibitor of the respiratory syncytial virus are described. This compound, RFI-641, emerged From analysis of the structure-activity relationship in a series of biphenyl triazine anionic compounds possessing specific anti-RSV activity. The key synthetic step involves coupling of diaminobiphenyl 11 with two equivalents of chlorotriazine 10 under microwave conditions. RFI-641 inhibited RSV in vitro and in vivo models. (C) 2001 Elsevier Science Ltd. All rights reserved.
The discovery of RFI-641 as a potent and selective inhibitor of the respiratory syncytial virus
摘要:
The design and synthesis of a new potent and selective inhibitor of the respiratory syncytial virus are described. This compound, RFI-641, emerged From analysis of the structure-activity relationship in a series of biphenyl triazine anionic compounds possessing specific anti-RSV activity. The key synthetic step involves coupling of diaminobiphenyl 11 with two equivalents of chlorotriazine 10 under microwave conditions. RFI-641 inhibited RSV in vitro and in vivo models. (C) 2001 Elsevier Science Ltd. All rights reserved.
Preparation and purification of antiviral disulfonic acid disodium salt
申请人:American Home Products Corporation
公开号:US20020151548A1
公开(公告)日:2002-10-17
The present invention provides a new process and intermediates for the production of antiviral compound 4′,4-bis-{4,6-bis-[3-(bis-carbamoyl-methyl-1-sulfamoyl)-phenylamino]-[1,3,5]triazin-2-ylamino}-biphenyl-2,2′-disulfonic acid and its pharmaceutically acceptable salts.
[EN] PREPARATION AND PURIFICATION OF ANTIVIRAL DISULFONIC ACID DISODIUM SALT<br/>[FR] PREPARATION ET PURIFICATION DE SEL DISODIQUE D'ACIDE SULFONIQUE ANTIVIRAL
申请人:WYETH CORP
公开号:WO2002062769A2
公开(公告)日:2002-08-15
The present invention provides a new process and intermediates for the production of antiviral compound 4',4-bis-4,6-bis-[bis-carbamoyl-methyl-1-sulfamoyl)phenylamino]-[1,3,5]triazin-2-ylamino}-biephenyl-2,2'-disulfonic acid and its pharmaceutically acceptable salts.